🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of acetaminophen, claiming the corporations concealed safety concerns that the medication presented to pediatric brain development.

The court filing arrives four weeks after Donald Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - throughout gestation and autism in children.

Paxton is suing the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic approved for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he stated they "misled consumers by profiting off of discomfort and promoting medication regardless of the potential hazards."

The company states there is no credible evidence tying acetaminophen to autism.

"These manufacturers misled for generations, deliberately risking countless individuals to line their pockets," the attorney general, a Republican, declared.

The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the health of American women and children."

On its online platform, Kenvue also mentioned it had "continuously evaluated the pertinent research and there is insufficient valid information that shows a proven link between using paracetamol and autism."

Organizations speaking for physicians and health professionals share this view.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the main ingredient in acetaminophen - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can create major wellness concerns if not addressed.

"In multiple decades of studies on the consumption of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the consumption of paracetamol in any stage of pregnancy leads to neurodevelopmental disorders in offspring," the group stated.

This legal action mentions current declarations from the previous government in claiming the medication is reportedly hazardous.

Last month, Trump raised alarms from medical authorities when he told women during pregnancy to "resist strongly" not to use Tylenol when ill.

The US Food and Drug Administration then issued a notice that physicians should consider limiting the use of Tylenol, while also declaring that "a proven link" between the medication and autism in young ones has remains unverified.

Health Secretary Kennedy, who manages the FDA, had pledged in spring to initiate "a massive testing and research effort" that would determine the source of autism in a limited time.

But authorities warned that finding a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complex mix of inherited and environmental factors - would prove challenging.

Autism is a form of enduring cognitive variation and disability that impacts how people perceive and relate to the world, and is recognized using physician assessments.

In his legal document, the attorney general - who supports Trump who is campaigning for US Senate - asserts the manufacturer and J&J "intentionally overlooked and sought to suppress the science" around paracetamol and autism.

The lawsuit attempts to require the firms "eliminate any promotional materials" that asserts Tylenol is safe for women during pregnancy.

The court case mirrors the grievances of a assembly of guardians of young ones with autism spectrum disorder and ADHD who sued the manufacturers of Tylenol in two years ago.

The court rejected the lawsuit, saying research from the plaintiffs' authorities was not conclusive.